| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 466 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 344 | 2021 |
| Diabetes mellitus and tuberculosis facts and controversies P Baghaei, M Marjani, P Javanmard, P Tabarsi, MR Masjedi Journal of Diabetes & Metabolic Disorders 12, 1-8, 2013 | 222 | 2013 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 136 | 2022 |
| First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ... International Journal of Infectious Diseases 13 (5), e236-e240, 2009 | 113 | 2009 |
| Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ... International immunopharmacology 90, 107205, 2021 | 96 | 2021 |
| Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ... International immunopharmacology 85, 106688, 2020 | 89 | 2020 |
| Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ... American journal of therapeutics 17 (1), 17-22, 2010 | 88 | 2010 |
| No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ... European journal of pharmacology 897, 173947, 2021 | 86 | 2021 |
| Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ... American journal of therapeutics 18 (2), e29-e34, 2011 | 79 | 2011 |
| Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis—need for earlier identification of nontuberculosis mycobacteria P Tabarsi, P Baghaei, P Farnia, N Mansouri, E Chitsaz, F Sheikholeslam, ... The American journal of the medical sciences 337 (3), 182-184, 2009 | 75 | 2009 |
| Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ... Frontiers in Immunology 12, 592727, 2021 | 74 | 2021 |
| Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm S Mahmoudi, M Rezaei, N Mansouri, M Marjani, D Mansouri Journal of clinical immunology 40, 974-976, 2020 | 68 | 2020 |
| Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency P Tabarsi, M Marjani, N Mansouri, P Farnia, S Boisson-Dupuis, ... Journal of clinical immunology 31, 537-539, 2011 | 66 | 2011 |
| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 63 | 2020 |
| Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis P Baghaei, P Tabarsi, P Farnia, M Marjani, FM Sheikholeslami, M Chitsaz, ... The Journal of Infection in Developing Countries 6 (01), 23-28, 2012 | 57 | 2012 |
| Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients FS Beigee, MP Toutkaboni, N Khalili, SA Nadji, A Dorudinia, M Rezaei, ... Pathology-Research and Practice 216 (10), 153228, 2020 | 53 | 2020 |
| A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 31, 2020 | 52 | 2020 |
| Fatal cytomegalovirus infection in an adult with inherited NOS2 deficiency SB Drutman, D Mansouri, SA Mahdaviani, AL Neehus, D Hum, R Bryk, ... New England Journal of Medicine 382 (5), 437-445, 2020 | 51 | 2020 |
| Rumen fermentation and microbial community composition influenced by live Enterococcus faecium supplementation LL Mamuad, SH Kim, AA Biswas, Z Yu, KK Cho, SB Kim, K Lee, SS Lee Amb Express 9 (1), 123, 2019 | 51* | 2019 |
